Danny Hsu: Are Elastic Compression Stockings Ineffective in Preventing Post-Thrombotic Syndrome?
Danny Hsu, President of THANZ, shared on LinkedIn about a recent article by Jean-Philippe Galanaud et al, published in RPTH Journal:
”The Great Stocking Debate: It’s Not About ‘If,’ It’s About ‘How Much’
For years, the efficacy of Elastic Compression Stockings (ECS) in preventing Post-Thrombotic Syndrome (PTS) has been controversial.
Are they ineffective, or are they just sitting in the drawer?
This RPTH Journal publication sheds more light on the debate, courtesy of Dr Jean-Philippe Galanaud’s team.
A new prespecified analysis of the CELEST trial suggests that adherence is the independent predictor we’ve been looking for.
The Data: The ‘50%’ Threshold
This double-blind trial compared PTS rates at 2 years based on how often patients actually wore their stockings.
The results reveal a clear ‘tipping point’:
- < 50% Adherence: 38.4% PTS rate
- 50–79% Adherence: 24.5% PTS rate
- ≥ 80% Adherence: 27.5% PTS rate
Clinical Pearl: The “All or Nothing” Myth
Perfection isn’t required. Wearing ECS ≥50% of the time significantly decreased the risk of PTS (aOR=0.51).
Who Benefits the Most?
The study identified a specific phenotype where adherence yields the highest return.
Non-obese patients with extensive DVT (≥4 venous segments) saw a massive benefit:
- Adherent (≥50%): 29.8% developed PTS
- Non-Adherent: 54.3% developed PTS
Risk Factors for PTS Identified:
- Obesity (aOR=4.73)
- Extensive DVT (≥4 segments aOR=15.59)
- Patient height
The Verdict:
Adherence matters, but we can be realistic with our patients.
Aiming for at least 50% wear time makes a clinically significant difference, particularly for our high-risk patients with extensive proximal DVT.
Does this data change how you counsel patients on compression adherence?”
Title: Impact of Adherence on Elastic Compression Stockings Efficacy to Prevent Post-Thrombotic Syndrome: a Prespecified Analysis of the CELEST Study
Authors: Jean-Philippe Galanaud, Céline Genty-Vermorel, Béatrice Terriat, Audrey Stansal, Damien Lanéelle, Claire Grange, Myriam Martin, Francis Couturaud, Patrick Mismetti, Alexa Comte, Claire Eychenne, François Verrière, Jean-Luc Bosson, CELEST investigators
Read the Full Article on RPTH Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026